Dana-Farber Cancer Institute
Disclosure(s): AbbVie: Advisor/Consultant; AbbVie (Inst): Grant/Research Support; Adaptive Biotechnologies: Advisor/Consultant; Aptitude Health: Honoraria; Ascentage Pharma: Advisor/Consultant; Ascentage Pharma (Inst): Grant/Research Support; AstraZeneca: Advisor/Consultant; AstraZeneca (Inst): Grant/Research Support; Axis Medical Education: Honoraria; BeiGene: Advisor/Consultant; Bio Ascend: Honoraria; Bristol Myers Squibb: Advisor/Consultant; Curio Science: Honoraria; Galapagos NV: Advisor/Consultant; Genentech: Advisor/Consultant; Genentech (Inst): Grant/Research Support; Genmab: Advisor/Consultant; Janssen: Advisor/Consultant; Lilly: Advisor/Consultant; Medscape: Honoraria; MEI Pharma: Advisor/Consultant; Merck: Advisor/Consultant; MingSight: Advisor/Consultant; Novartis (Inst): Grant/Research Support; Nuvalent Inc: Advisor/Consultant; Peerview: Honoraria; Physicians’ Education Resource: Honoraria; PlatformQ Health: Honoraria; Plexus: Honoraria; Research to practice: Honoraria; Secura Bio: Advisor/Consultant; Secura Bio (Inst): Grant/Research Support; Takeda: Advisor/Consultant; TG Therapeutics: Advisor/Consultant; TG Therapeutics (Inst): Grant/Research Support; UptoDate: Royalties